Mutation screening of the <i>c‐MYB</i> negative regulatory domain in acute and chronic myeloid leukaemia

Jodi K. Lutwyche(South Australia Pathology), Thomas J. Gonda(University of South Australia), Timothy P. Hughes(Royal Adelaide Hospital), Rebecca A. Keough(University of Adelaide)
British Journal of Haematology
September 1, 2001
10.1046/j.1365-2141.2001.02966.x
Cited by 10

Related Papers

A family of cytokine-inducible inhibitors of signalling
|Nature|1997|2.1k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
|Nature|2008|1.1k
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study
|Blood|2013|705
MYB function in normal and cancer cells
|Nature reviews. Cancer|2008|627